| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | 86.92% | Mizuho | $80 → $50 | Maintains | Buy |
| 08/31/2023 | 180.37% | JP Morgan | → $75 | Initiates Coverage On | → Overweight |
| 07/21/2023 | 232.71% | Stephens & Co. | → $89 | Reiterates | Overweight → Overweight |
| 06/29/2023 | 195.33% | Citigroup | → $79 | Initiates Coverage On | → Buy |
| 04/21/2023 | 232.71% | Stephens & Co. | → $89 | Reiterates | → Overweight |
| 04/21/2023 | 311.21% | Mizuho | $95 → $110 | Maintains | Buy |
| 04/17/2023 | 292.52% | BTIG | $100 → $105 | Maintains | Buy |
| 02/28/2023 | 232.71% | Stephens & Co. | $87 → $89 | Maintains | Overweight |
| 01/24/2023 | 255.14% | Mizuho | $70 → $95 | Maintains | Buy |
| 12/28/2022 | 225.23% | Stephens & Co. | $90 → $87 | Maintains | Overweight |
| 10/14/2022 | 236.45% | Stephens & Co. | → $90 | Reinstates | → Overweight |
| 10/13/2022 | 161.68% | Mizuho | → $70 | Initiates Coverage On | → Buy |
| 10/07/2022 | 273.83% | BTIG | $90 → $100 | Maintains | Buy |
| 08/24/2022 | 300% | B. Riley Securities | → $107 | Initiates Coverage On | → Buy |
| 08/09/2022 | 142.99% | Goldman Sachs | $57 → $65 | Maintains | Neutral |
| 06/24/2022 | 236.45% | BTIG | $105 → $90 | Maintains | Buy |
| 05/11/2022 | 113.08% | Goldman Sachs | $67 → $57 | Maintains | Neutral |
| 04/22/2022 | 311.21% | BTIG | $95 → $110 | Maintains | Buy |
| 03/21/2022 | 150.47% | Goldman Sachs | $78 → $67 | Maintains | Neutral |
| 11/10/2021 | 236.45% | Stephens & Co. | $88 → $90 | Maintains | Overweight |
| 08/03/2021 | 191.59% | Goldman Sachs | $68 → $78 | Maintains | Neutral |
| 06/23/2021 | 228.97% | BTIG | $82 → $88 | Maintains | Buy |
| 02/10/2021 | 199.07% | Cowen & Co. | $60 → $80 | Maintains | Outperform |
| 05/14/2020 | -25.23% | Goldman Sachs | → $20 | Initiates Coverage On | → Neutral |
| 03/23/2020 | -14.02% | Stephens & Co. | $30 → $23 | Maintains | Overweight |
| 03/17/2020 | 30.84% | BTIG | $40 → $35 | Maintains | Buy |
| 06/28/2019 | 8.41% | Wells Fargo | → $29 | Initiates Coverage On | → Outperform |
| 06/07/2019 | 38.32% | Stephens & Co. | → $37 | Initiates Coverage On | → Overweight |
What is the target price for Establishment Labs Hldgs (ESTA)?
The latest price target for Establishment Labs Hldgs (NASDAQ: ESTA) was reported by Mizuho on November 8, 2023. The analyst firm set a price target for $50.00 expecting ESTA to rise to within 12 months (a possible 86.92% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Establishment Labs Hldgs (ESTA)?
The latest analyst rating for Establishment Labs Hldgs (NASDAQ: ESTA) was provided by Mizuho, and Establishment Labs Hldgs maintained their buy rating.
When is the next analyst rating going to be posted or updated for Establishment Labs Hldgs (ESTA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Establishment Labs Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Establishment Labs Hldgs was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating Establishment Labs Hldgs (ESTA) correct?
While ratings are subjective and will change, the latest Establishment Labs Hldgs (ESTA) rating was a maintained with a price target of $80.00 to $50.00. The current price Establishment Labs Hldgs (ESTA) is trading at is $26.75, which is out of the analyst's predicted range.